The TAIEX yesterday retreated 5.83 percent to close at 8,681.34 points, the lowest in 42 months, as foreign and domestic institutional investors continue a sell-off amid the escalating worldwide spread of COVID-19, analysts said.
The benchmark index opened down 133.39 points at 9,085.28 — which was lower than the 10-year moving average of 9,110 points — and continued falling by a total of 695 points in the early morning session, before slowly rebounding to close down 537.33 points at the end of trading, Taiwan Stock Exchange (TWSE) data showed.
The TAIEX has fallen 28 percent from its peak of 12,179 points, registered on Jan. 14, a considerable and rarely seen drop, but analysts said that they could not predict the bottom for the market, given the ongoing spread of the coronavirus.
Photo: Liao Chen-huei, Taipei Times
“The deterioration in the local equity market could be attributed to sell-offs by foreign and domestic institutional investors. There will likely be a turning point once they stop selling, but it is hard to forecast when,” Capital Investment Trust Corp (群益投信) fund manager Daniel Tsai (蔡彥正) told the Taipei Times by telephone yesterday.
“Cash is king now. Institutional investors would prefer to decrease their holdings of risky assets, as they predict their value to decline amid volatile trading,” Tsai said.
Besides taking the “flight-to-quality” action, some institutional investors sold local shares after a computer-activated trading tool unleashed stop-loss orders when prices of stocks they bought earlier had declined more than 30 percent, Tsai said.
As the New Taiwan dollar yesterday weakened against the US dollar, it seemed that some foreign investors immediately moved funds out of Taiwan after selling local equities, partially to support their fund management businesses, he said.
Foreign institution investors yesterday sold a net NT$21.22 billion (US$695.6 million) of local shares, slightly down from the average of NT$28 billion they sold over the previous three days.
It would still take days to observe if the sell-offs would ease, he said.
Domestic securities investment trust companies also sold a net of NT$700 million of local shares, up from the previous three day’s average of NT$209 million, TWSE data showed.
“Quantitative easing monetary policy, rate cuts and expansionary fiscal policy would be a bit helpful, but not very likely to alter the trend. People do not lack funds, but they need to see effective treatments for COVID-19 before regaining confidence in the global economy,” Tsai said.
Malaysia is scrambling to protect its assets as the descendants of the last sultan of the remote Philippine region of Sulu look to enforce a US$15 billion arbitration award in a dispute over a colonial-era land deal. In 1878, two European colonists signed a deal with the sultan for the use of his territory in present-day Malaysia — an agreement that independent Malaysia honored until 2013, paying the monarch’s descendants about US$1,000 per year. Now, 144 years later after the original deal, Malaysia is on the hook for the second-largest arbitration award on record for stopping the payments after a bloody incursion
RECOVERED CONFIDENCE: As market rationality returns, Taiwanese stocks that have lagged behind their US peers might soon catch up, Allianz researchers said Local shares last week defied heavy pressure from China’s military drills in waters around Taiwan, and investors this week are expected to pay attention to earnings results from several tech heavyweights as well as the latest economic data on exports and GDP. The TAIEX closed at 15,036.04 points on Friday, posting a weekly increase of 0.24 percent from 15,000.07 on July 29, Taiwan Stock Exchange data showed. Over the same period, the FTSE TWSE Taiwan 50 Index, which comprises Taiwan’s top 50 stocks in terms of market capitalization, closed up 0.93 percent at 11,750.15 points, while the Formosa Stock Index, which measures
Pharmaceutical start-up AcadeMab Biomedical Inc (研生生醫) said it has been developing a COVID-19 antibody drug, an endeavor not being undertaken by many other Taiwanese pharmaceutical firms. The company was spun off from Academia Sinica’s Institute of Cellular and Organismic Biology in 2020 and has only 16 employees. It has set its sights on the innovative field of the monoclonal antibody treatment of tumors. The start-up began developing antibody drugs in January, after seeing that COVID-19 vaccines could not effectively protect people from new variants of SARS-CoV-2, AcadeMab Biomedical chief strategy officer Pearl Fong (俸清珠) said in an interview with the Taipei Times
FORECAST EXCEEDED: China’s curbs on some Taiwanese goods are unlikely to affect trade given inter-reliance in the electronics industries, a finance ministry official said Exports last month spiked 14.2 percent to US$43.32 billion, the second-highest increase on record and the 25th consecutive month of gains, driven by global demand for electronics used in high-performance computing and vehicles, the Ministry of Finance said yesterday. The ministry expects the trend to sustain this month and beyond, although the pace could slow due to inventory corrections for laptops, smartphones and other consumer electronics. “The July results proved stronger than expected despite rising fears over economic uncertainty,” Department of Statistics Director-General Beatrice Tsai (蔡美娜) said, adding that a high sales season in the West and stabilized COVID-19 infections in China
RSS